Average Co-Inventor Count = 3.81
ph-index = 21
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. National Institutes of Health, a Component of the US Dept. of Health & Human Services (48 from 3,427 patents)
2. University of Michigan (32 from 3,337 patents)
3. Sanofi (16 from 1,437 patents)
4. USA As Represented by Secretary of the Navy (8 from 16,045 patents)
5. Dana-farber-cancer Institute Inc. (8 from 1,201 patents)
6. Genetics Institute, Inc. (8 from 389 patents)
7. University of Washington (4 from 2,088 patents)
8. Other (3 from 832,448 patents)
9. The Scripps Research Institute (2 from 1,186 patents)
10. Glaxosmithkline Biologicals Sa (2 from 531 patents)
11. Warner-lambert Company (1 from 2,536 patents)
12. Duke University (1 from 2,001 patents)
13. Janssen Vaccines & Prevention B.v. (1 from 115 patents)
14. US Government As Represented by the Secretary of the Army (8,682 patents)
15. Crucell Holland B.v. (146 patents)
108 patents:
1. 12454553 - Antigenic multimeric respiratory syncytial virus polypeptides
2. 12281336 - Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and E2 structural proteins
3. 12227573 - Trispecific binding proteins, methods, and uses thereof
4. 12168675 - Virus-like particles and methods of use
5. 12121562 - Antigenic Epstein Barr virus polypeptides
6. 12071454 - Antigenic respiratory syncytial virus polypeptides
7. 12053503 - Antigenic epstein barr virus polypeptides
8. 12005115 - Epstein-barr virus vaccines
9. 11993636 - Antigenic OspA polypeptides
10. 11992523 - Method for producing chikungunya virus (CHIKV) virus-like particles comprising the C, E2, and E1 structural proteins
11. 11932704 - Trispecific and/or trivalent binding proteins
12. 11913013 - Chimpanzee adenoviral vector-based filovirus vaccines
13. 11904009 - Ferritin proteins
14. 11779651 - Bivalent, bispecific binding proteins for prevention or treatment of HIV infection
15. 11718647 - Virus-like particles and methods of use